Novo Integrated Sciences, through its wholly owned subsidiary, Novo Healthnet Limited (NHL), delivers multidisciplinary primary health care related services and products through the integration of medical technology, interconnectivity, improved therapeutics, diagnostic solutions, personalized product offerings, and rehabilitative science. Co.'s clinicians and practitioners provide certain multidisciplinary primary health care services, and related products. NHL's team of multidisciplinary primary health care clinicians and practitioners provide assessment, diagnosis, education and primary prevention for an array of orthopedic, musculoskeletal, sports injury, and neurological conditions. The NVOS average annual return since 2021 is shown above.
The Average Annual Return on the NVOS average annual return since 2021 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether NVOS average annual return since 2021 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the NVOS average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|